ES2122005T3 - Medicamento que contiene (-)-metrifonato. - Google Patents

Medicamento que contiene (-)-metrifonato.

Info

Publication number
ES2122005T3
ES2122005T3 ES93910008T ES93910008T ES2122005T3 ES 2122005 T3 ES2122005 T3 ES 2122005T3 ES 93910008 T ES93910008 T ES 93910008T ES 93910008 T ES93910008 T ES 93910008T ES 2122005 T3 ES2122005 T3 ES 2122005T3
Authority
ES
Spain
Prior art keywords
metrifonate
pct
product containing
medicinal product
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93910008T
Other languages
English (en)
Inventor
Michael Boberg
Wolfgang Kanhai
Armin Kern
Volker Dr Muschalek
Ulrich Pleiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2122005T3 publication Critical patent/ES2122005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UN MEDICAMENTO QUE CONTIENE METRIFONATO, DISPONIENDO SOLAMENTE COMO SUSTANCIA ACTIVA EL (-) ENANTIOMERO DE METRIFONATO. EL (-) - METRIFONATO ES UN INHIBIDOR DE COLINESTERASA SIGNIFICATIVAMENTE MEJOR QUE LA MEZCLA RACEMICA. ESTO PERMITE QUE SE REDUZCA LA CANTIDAD DE SUSTANCIA ACTIVA Y CON ELLO DISMINUYA EL TAMAÑO DE LAS TABLETAS.
ES93910008T 1992-05-26 1993-05-17 Medicamento que contiene (-)-metrifonato. Expired - Lifetime ES2122005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4217396A DE4217396A1 (de) 1992-05-26 1992-05-26 Metrifonat enthaltendes Arzneimittel

Publications (1)

Publication Number Publication Date
ES2122005T3 true ES2122005T3 (es) 1998-12-16

Family

ID=6459760

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93910008T Expired - Lifetime ES2122005T3 (es) 1992-05-26 1993-05-17 Medicamento que contiene (-)-metrifonato.

Country Status (10)

Country Link
US (1) US5629300A (es)
EP (1) EP0669826B1 (es)
JP (1) JPH07507280A (es)
AT (1) ATE169819T1 (es)
CA (1) CA2136548A1 (es)
DE (2) DE4217396A1 (es)
DK (1) DK0669826T3 (es)
ES (1) ES2122005T3 (es)
MX (1) MX9302986A (es)
WO (1) WO1993024130A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807931D0 (en) * 1998-04-15 1998-06-10 Medical Res Council Improvements in or relating to protease inhibitors
DE19857716A1 (de) * 1998-12-15 2000-06-21 Bayer Ag Neue feste Formulierung von Metrifonat
US11446241B2 (en) 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
CA2917815C (en) 2013-07-29 2022-08-30 Attillaps Holdings Organophosphates for treating afflictions of the skin
PT3157534T (pt) 2014-06-19 2022-08-04 Attillaps Holdings Inibidores de acetilcolinestérase para o tratamento de condições da dermatológicas

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950658A (en) * 1988-12-06 1990-08-21 Board Of Trustees Of Southern Illinois Univ. Method of medical treatment of Alzheimer's disease

Also Published As

Publication number Publication date
ATE169819T1 (de) 1998-09-15
US5629300A (en) 1997-05-13
EP0669826B1 (de) 1998-08-19
MX9302986A (es) 1993-12-01
DE4217396A1 (de) 1993-12-02
JPH07507280A (ja) 1995-08-10
CA2136548A1 (en) 1993-12-09
DE59308900D1 (de) 1998-09-24
EP0669826A1 (de) 1995-09-06
DK0669826T3 (da) 1999-05-25
WO1993024130A1 (de) 1993-12-09

Similar Documents

Publication Publication Date Title
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
FI954990A0 (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
CA2229077A1 (en) Lipid metabolism improving agent
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ATE157536T1 (de) Synergistische lichtschutzkombinationen und kosmetische und dermatologische formulierungen, solche kombinationen enthaltend
ES2090712T3 (es) Medicamento agudo que contiene ibuprofeno y su uso.
IL139318A (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
AU8332791A (en) Oral pharmaceutical compositions containing melatonin
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments
ATE169819T1 (de) (-)-metrifonat enthaltendes arzneimittel
MX9203361A (es) Composiciones farmaceuticas que contienen cloruro de galio.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
NO305560B1 (no) Krystallinsk 3-(4-heksyloksy-1,2,5-tiadiazol-3-yl)-1,2,5,6-tetrahydro-1-metylpyridin-(+)-L-hydrogentartrat, farmas°ytiske preparater som omfatter forbindelsen, samt anvendelse av forbindelsen til fremstilling av et medikament
PT1001942E (pt) Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem
HUT73231A (en) Pharmaceutical compositions with 17-beta-monosubstituted-carbamoyl-4-aza-5-alpha-androst-1-en-3-ones for treatment of chronic prostatitis
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
ES2059633T3 (es) 2-terc.-butil-4-cloro-5-(4-terc.-butilbenciltio)-3(2h)-piridazinona para la lucha contra los moluscos.
AU7025087A (en) Pharmaceutical compositions for the therapy of cerebropathies on functional and organic base
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
FR2393798A1 (fr) Derives des tetrahydro-1,3,5-thiadiazine-4-one utilisables en tant que compositions insecticides et miticides
AU665397B2 (en) Fungicidal compositions

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 669826

Country of ref document: ES